108 related articles for article (PubMed ID: 26137085)
1. XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.
Fan J; Fan Y; Kang X; Zhao L
Oncol Lett; 2015 May; 9(5):2425-2429. PubMed ID: 26137085
[TBL] [Abstract][Full Text] [Related]
2. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
He XF; Wei W; Li JL; Shen XL; Ding DP; Wang SL; Liu ZZ; Qin JB; Wu LX; Xie DL
Gene; 2013 Jul; 523(1):10-9. PubMed ID: 23562721
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility.
Zhang LZ; Li YS; Liu HZ
Genet Mol Res; 2015 Nov; 14(4):14831-9. PubMed ID: 26600544
[TBL] [Abstract][Full Text] [Related]
4. XRCC3 T241M polymorphism and lung cancer risk in the Han Chinese population: a meta-analysis.
Zhang JH; Wen QL; Yang C; Li AL; Liu Y; Li XS
Genet Mol Res; 2014 Nov; 13(4):9505-13. PubMed ID: 25501160
[TBL] [Abstract][Full Text] [Related]
5. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.
He XF; Wei W; Su J; Yang ZX; Liu Y; Zhang Y; Ding DP; Wang W
Mol Biol Rep; 2012 May; 39(5):5125-34. PubMed ID: 22161248
[TBL] [Abstract][Full Text] [Related]
6. Association between XRCC3 T241M polymorphism and glioma risk: a meta-analysis.
Feng Y; Zeng M; Xu Q
Tumour Biol; 2014 Jun; 35(6):5589-92. PubMed ID: 24633885
[TBL] [Abstract][Full Text] [Related]
7. Association between the XRCC3 Thr241Met polymorphism and breast cancer risk: an updated meta-analysis of 36 case-control studies.
Mao CF; Qian WY; Wu JZ; Sun DW; Tang JH
Asian Pac J Cancer Prev; 2014; 15(16):6613-8. PubMed ID: 25169497
[TBL] [Abstract][Full Text] [Related]
8. Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Li L; Zu XY; Wang YJ
Asian Pac J Cancer Prev; 2012; 13(10):5201-5. PubMed ID: 23244135
[TBL] [Abstract][Full Text] [Related]
9. XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.
Liu C; Wang H
Tumour Biol; 2013 Aug; 34(4):2249-54. PubMed ID: 23558966
[TBL] [Abstract][Full Text] [Related]
10. DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis.
Ji RB; Qian YS; Hu AR; Hu YR
Genet Mol Res; 2015 Dec; 14(4):15988-96. PubMed ID: 26662391
[TBL] [Abstract][Full Text] [Related]
11. Association Between X-Ray Cross-complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis.
Lu W; Wu G; Zhang B
Med Sci Monit; 2015 Dec; 21():3978-85. PubMed ID: 26687776
[TBL] [Abstract][Full Text] [Related]
12. Association between the DNA Repair Gene XRCC3 rs861539 Polymorphism and Risk of Osteosarcoma: a Systematic Review and Meta-Analysis.
Sobhan MR; Forat Yazdi M; Mazaheri M; Zare Shehneh M; Neamatzadeh H
Asian Pac J Cancer Prev; 2017 Feb; 18(2):549-555. PubMed ID: 28345844
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the influence of X-ray repair cross-complementing group 3 rs861539 polymorphism and cutaneous melanoma susceptibility.
Zeng Y; Ma F; Gao W; Wang Y; Liu C
Arch Dermatol Res; 2016 Apr; 308(3):173-81. PubMed ID: 26922354
[TBL] [Abstract][Full Text] [Related]
14. Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis.
Sahami-Fard MH; Mousa Mayali AR; Tajehmiri A
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4599-4608. PubMed ID: 27892671
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in DNA repair genes XRCC1 and XRCC3, occupational exposure to arsenic and sunlight, and the risk of non-melanoma skin cancer in a European case-control study.
Surdu S; Fitzgerald EF; Bloom MS; Boscoe FP; Carpenter DO; Haase RF; Gurzau E; Rudnai P; Koppova K; Vahter M; Leonardi G; Goessler W; Kumar R; Fletcher T
Environ Res; 2014 Oct; 134():382-9. PubMed ID: 25218703
[TBL] [Abstract][Full Text] [Related]
16. Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.
Fang F; Wang J; Yao L; Yu XJ; Yu L; Yu L
Med Oncol; 2011 Dec; 28(4):999-1003. PubMed ID: 20549576
[TBL] [Abstract][Full Text] [Related]
17. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F; Liang Y; Chen L; Zhang F; Jiang J
Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
[TBL] [Abstract][Full Text] [Related]
18. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
[TBL] [Abstract][Full Text] [Related]
19. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
[TBL] [Abstract][Full Text] [Related]
20. XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.
Chen X; Wang Z; Yan Y; Li P; Yang Z; Qin L; Mo W
PLoS One; 2014; 9(1):e84195. PubMed ID: 24454720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
